Literature DB >> 16391530

The phantom menace.

Andrea Rinaldi.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16391530      PMCID： PMC1369240          DOI： 10.1038/sj.embor.7400608

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  17 in total

1.  Dutch government urged to inform public of blood mistakes.

Authors:  Grainger Laffan
Journal:  Lancet       Date:  2005 Jun 25-Jul 1       Impact factor: 79.321

2.  Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.

Authors:  Philip Meuleman; Louis Libbrecht; Rita De Vos; Bernard de Hemptinne; Kris Gevaert; Joël Vandekerckhove; Tania Roskams; Geert Leroux-Roels
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

3.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

Authors:  Markus Reiser; Holger Hinrichsen; Yves Benhamou; Henk W Reesink; Heiner Wedemeyer; Cristina Avendano; Neus Riba; Chan-Loi Yong; Gerhard Nehmiz; Gerhard G Steinmann
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

5.  Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

Authors:  Holger Hinrichsen; Yves Benhamou; Heiner Wedemeyer; Markus Reiser; Roel E Sentjens; José L Calleja; Xavier Forns; Andreas Erhardt; Jens Crönlein; Ricardo L Chaves; Chan-Loi Yong; Gerhard Nehmiz; Gerhard G Steinmann
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  Challenges and successes in developing new therapies for hepatitis C.

Authors:  Raffaele De Francesco; Giovanni Migliaccio
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

7.  Unscrambling hepatitis C virus-host interactions.

Authors:  Francis V Chisari
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

Review 8.  Chronic hepatitis C in African Americans and other minority groups.

Authors:  Jaquelyn Fleckenstein
Journal:  Curr Gastroenterol Rep       Date:  2004-02

9.  An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.

Authors:  Daniel Lamarre; Paul C Anderson; Murray Bailey; Pierre Beaulieu; Gordon Bolger; Pierre Bonneau; Michael Bös; Dale R Cameron; Mireille Cartier; Michael G Cordingley; Anne-Marie Faucher; Nathalie Goudreau; Stephen H Kawai; George Kukolj; Lisette Lagacé; Steven R LaPlante; Hans Narjes; Marc-André Poupart; Jean Rancourt; Roel E Sentjens; Roger St George; Bruno Simoneau; Gerhard Steinmann; Diane Thibeault; Youla S Tsantrizos; Steven M Weldon; Chan-Loi Yong; Montse Llinàs-Brunet
Journal:  Nature       Date:  2003-10-26       Impact factor: 49.962

10.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728
View more
  1 in total

1.  Inhibitor-induced structural change in the HCV IRES domain IIa RNA.

Authors:  Ryan B Paulsen; Punit P Seth; Eric E Swayze; Richard H Griffey; Jack J Skalicky; Thomas E Cheatham; Darrell R Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-01       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.